Compare Albertsons Companies Inc (ACI) vs Boston Scientific Corporation (BSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Albertsons Companies Inc vs Boston Scientific Corporation — how do they compare? Albertsons Companies Inc trades at $12.35 (market cap $5.95B), while Boston Scientific Corporation trades at $50.96 (market cap $74.19B). The key difference: Boston Scientific Corporation is far larger — about 12.5× Albertsons Companies Inc's market cap, and Albertsons Companies Inc pays a 5.55% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| ACI | BSX | |
|---|---|---|
Market Cap | $5.95B | $74.19B |
Sector | Consumer Staples | Health |
52-Week High | $19.74 | $108.14 |
52-Week Low | $11.03 | $42.63 |
Enterprise Value | $21.35B | $86.27B |
Dividend Yield | 5.55% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Albertsons Companies Inc
Albertsons is the second-largest traditional grocer in America, operating 2,276 stores under 24 banners in 34 states (as of the end of fiscal 2021). Around 75% of stores have pharmacies, while nearly 20% also sell fuel. Albertsons has a significant private-label operation, accounting for around 20% of sales (excluding fuel). While its own brand assortment is mainly manufactured by third parties, Albertsons operates 20 food production plants (as of the end of fiscal 2021). Albertsons is a top-two grocer in two thirds of its major markets (as of early 2022, according to company data), and virtually all of its sales come from the United States.
Read more on ACI →About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →
